Insider filing · MRNA

Noubar Afeyan sold $703K of Moderna (MRNA)

Executed Dec 11 2025, disclosed Dec 15 2025, 4 days later.

Returns are measured on stock purchases only.

NA Noubar Afeyan Director profile →

Noubar Afeyan (Director) filed 4 Form 4 reports in the trailing twelve months (2 purchases, 2 sales), most often in Generate Biomedicines, Inc. (GENB). Across 2 priced purchase filings, the average 21-session return was -4.2% from execution and -4.2% from disclosure (delay-adjusted; derived). The largest single filing was $75.0M of GENB (4,687,500 sh across 3 lots, as filed), executed Mar 2.

MRNA Moderna, Inc. MRNA · Healthcare · 20 filings in 24 months ticker →

Healthcare · Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→